Nelia Malubay

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.

Z. Bhutta, S. Juvekar, E. Marchetti, 2014, The Lancet. Infectious diseases.